Kymera Therapeutics, Inc. <KYMR.O>: JPMorgan raises target price to $140 from $121
KYMR•Related News
UBS launches cash tender offers for nine Credit Suisse note series, including USD 2 billion capped purchase program
UBS•
Hawkeye 360 Inc <HAWK.N>: Berenberg initiates coverage with buy rating; target price $24
HAWK•
Winamp Group Says Jamendo Amended Complaint Formally Served On NVIDIA, Case Moves To Next Phase
NVDA•
Nasdaq trade halt continues <LAWR.O> reason not available at 03:58 AM
LAWR•
Nasdaq Trade Halt Continues <OST.O> Reason Not Available at 03:58 AM
OST•